Schisandrin A protects against lipopolysaccharide-induced mastitis through activating Nrf2 signaling pathway and inducing autophagy

Int Immunopharmacol. 2020 Jan:78:105983. doi: 10.1016/j.intimp.2019.105983. Epub 2019 Nov 22.

Abstract

Schisandrin A (Sch A), a dibenzocyclooctadiene lignan extracted from Schisandra chinensis (Turcz.) Baill., has anti-oxidant and anti-inflammatory effects, but the effect on masitits has not been studied. Therefore, we investigated the effect of Sch A in cell and mouse models of lipopolysaccharide (LPS)-induced mastitis. Studies in vivo showed that Sch A reduced LPS-induced mammary injury and the production of pro-inflammatory mediators. Sch A also decreased the levels of pro-inflammatory mediators and activated nuclear factor-E2 associated factor 2 (Nrf2) signaling pathway in mouse mammary epithelial cells (mMECs). The Nrf2 inhibitor partially abrogated the downregulation of Sch A on LPS-induced inflammatory response. In addition, LPS stimulation suppressed autophagy, while both Sch A and the autophagy inducer rapamycin activated autophagy in mMECs, which down-regulated inflammatory response. Sch A also restrained LPS-induced phosphorylation of mammalian target of rapamycin (mTOR) and activated AMP-activated protein kinase (AMPK) and unc-51 like kinase 1 (ULK1). In summary, these results suggest that Sch A exerts protective effects in LPS-induced mastitis models by activating Nrf2 signaling pathway and inducing autophagy and the autophagy is initiated by suppressing mTOR signaling pathway and activating AMPK-ULK1 signaling pathway.

Keywords: AMPK-ULK1; Autophagy; Mastitis; Nrf2; Schisandrin A; mTOR.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Autophagy / drug effects*
  • Cells, Cultured
  • Cyclooctanes / pharmacology
  • Cyclooctanes / therapeutic use*
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Female
  • Interleukin-1beta / genetics
  • Lignans / pharmacology
  • Lignans / therapeutic use*
  • Lipopolysaccharides
  • Mammary Glands, Animal / drug effects
  • Mastitis / chemically induced
  • Mastitis / drug therapy*
  • Mastitis / metabolism
  • Mastitis / pathology
  • Mice, Inbred C57BL
  • NF-E2-Related Factor 2 / metabolism*
  • Peroxidase / metabolism
  • Polycyclic Compounds / pharmacology
  • Polycyclic Compounds / therapeutic use*
  • Signal Transduction / drug effects
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Anti-Inflammatory Agents
  • Cyclooctanes
  • IL1B protein, mouse
  • Interleukin-1beta
  • Lignans
  • Lipopolysaccharides
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Polycyclic Compounds
  • Tumor Necrosis Factor-alpha
  • schizandrin A
  • Peroxidase